Stocks are sharply lower today, with the Nasdaq suffering its worst loss of the month. Here’s a look at eight IBD 50 stocks bucking the market sell-off: Horizon Pharma (HZNP) gained as much as 3% early in the session before easing in midafternoon trade. Horizon shares have risen 143% this year and have had three strong weeks. Pinnacle Entertainment (PNK) shares were up 1% in midafternoon trade. The stock jumped out of a price consolidation on
High-rated specialty-drug stock Horizon Pharma (HZNP) got an upgrade Tuesday in the wake of its deal to acquire an orphan-drug company. Piper Jaffray analyst David Amsellem lifted his rating to overweight from neutral and his price target to 31 from 21 on the strength of Horizon’s $1.1 billion buyout of Hyperion Therapeutics (HPTX). Amsellem singled out Hyperion’s drug Ravicti, a treatment for rare urea cycle disorders (UCD), calling it a “game
Specialty drugmaker Horizon Pharma (HZNP) beat analysts’ Q4 expectations and raised its 2015 guidance Friday, sending its stock up 10% to a new high. Horizon’s revenue in the quarter more than tripled to $103.8 million, about $8 million above analysts’ consensus, according to Thomson Reuters. Excluding one-time items, the firm made 27 cents a share, reversing a year-earlier loss and beating estimates by 5 cents. For the year, sales jumped 300% to